BCR and myeloid sarcoma: The presentation of these specific BCR-derived peptides activates memory CD4+ T cells in MS patients (108) Moreover, the CDR3 sequences of CSF B cells from MS patients contain more T-cell-exposed motifs, which have a higher potential to evade immune tolerance and activate CD4+ T cells compared to B cells from patients with other inflammatory neurological disorders (109).